000960 China Merchants Medicine and Health Industry Stock Fund

000960 is the ticker symbol of China Merchants Medicine Health Industry Stock Fund. China Merchants Health Industry Investment Co. was founded on 03/07/2018. Legal representative Yu Shixin, the company's scope of business includes: investment in medicine, medical care, medical and health care industry with its own funds (shall not be engaged in or disguised as statutory financial business); technology development, transfer, consulting and service of pharmaceutical products; wholesale and retail of medicinal herbs, pharmaceuticals (limited to branch operations), medical equipment (limited to branch operations), mechanical equipment, electromechanical equipment; self-supporting and agent goods and technology Import and export, etc.

Equity Investment Strategy

The Fund's equity investment adopts a bottom-up approach, based on in-depth fundamental research, from both quantitative and qualitative aspects, through in-depth fundamental research and analysis, selected pharmaceutical and healthcare industry and its related industries in the fundamentals of the good, good development prospects and the value of the underestimated high-quality listed companies to invest actively in the construction of stock and bond portfolios. The portfolio of stocks and bonds is constructed.

1. Definition of Pharmaceutical and Healthcare Industry Stocks

The pharmaceutical and healthcare industry referred to by this fund consists of companies engaged in the research and development, production or sales of pharmaceutical and healthcare-related products or services, including but not limited to the chemical pharmaceutical industry, the traditional Chinese medicine industry, the biologics industry, the pharmaceutical business industry, the medical device industry and the medical service industry.

2. Industry Allocation Strategy

The pharmaceutical and healthcare industry can be divided into different subsectors based on the types of products and services provided. The Fund will consider various factors such as economic, social and policy factors, market demand trends, industry competition patterns, technology levels and development trends, etc., to make industry allocations of equity assets among various subsectors.

3, individual stock selection

Based on the industry allocation, the fund mainly through the consideration of the following factors for the comprehensive assessment of the investment value of listed companies in the pharmaceutical and health industry: endogenous growth factors (such as the competitive advantage of the product, the product's life cycle, sales capacity, management capacity, research and development capabilities, growth potential, profitability, financial institutions, corporate governance structure and other factors) , exogenous growth factors (such as overall listing, mergers and acquisitions and reorganization and other factors). On this basis, the Fund will select listed companies with strong competitive advantages.